Abeona Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Abeona Therapeutics

09/08/2023 14:32

* Abeona Therapeutics Inc  ABEO.OQ  reported a quarterly
adjusted
loss of 92 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 68 cents per share.
    * Revenue rose 250% to $3.50 million from a year ago;
analysts
expected zero. 
    * Abeona Therapeutics Inc's reported EPS for the quarter was
a
loss of 92 cents​.
    * The mean earnings estimate of analysts had fallen by
about 9.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Abeona Therapeutics Inc shares had fallen by 26.1% this
quarter and lost 3.2% so far this year.
    * The company reported a quarterly loss of $16.65 million.
    * Wall Street's median 12-month price target for Abeona
Therapeutics Inc is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.68          -0.92          Missed
 Mar. 31 2023      -0.58          -0.54          Beat
 Dec. 31 2022      -0.75          1.53           Beat
 Sep. 30 2022      -1.75          -1.48          Beat